Search results
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
AOL· 5 days agoNovavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine giant Sanofi (SNY) would invest $1.2 billion in a deal for Novavax's COVID- ...
GameStop’s 'Roaring Kitty' surge doesn’t mean meme stock rally has legs
Yahoo Finance· 2 days agoEconomics shows that in prior bubbles, including the 2021 meme stock surge, margin debt rose in line...
Investors Are Pouring Into These Gaming And Retail ETFs On Gamestop's Latest Run
Benzinga via Yahoo Finance· 21 hours agoGameStop Corp (NYSE:GME) is once again sending shockwaves through the markets, with investors...
Utility stocks are on fire — here are Wall Street analysts' top picks
Yahoo Finance· 4 days agoSouthern shares are up 9% year to date. The stock has 11 Buy, seven Hold, and three Sell analyst...
Meta Stock Continues To Fall: Is The Era Of AI Gains Coming To An End?
Benzinga via Yahoo Finance· 3 days agoMeta Platforms, Inc. (NASDAQ:META) has been grappling with declining investor confidence despite...
Housing costs rise at slowest annual rate in two years as inflation eases
Yahoo Finance via AOL· 17 hours agoHowever...Madera Residential, a Texas-based apartment owner, told Yahoo Finance in an interview....
Wall Street surges as US inflation slows to 3.4% and FTSE closes higher
Yahoo Finance UK· 24 hours agoThe risk is that if interest rates linger for a lot longer, it will push the economy into a much...
European and US markets cautious as traders look to key inflation data
Yahoo Finance UK· 2 days agoGlobal markets are looking ahead to the Consumer Price Inflation print on Wednesday in the US, which...
Warren Buffett Believes In S&P 500 Index Funds - But Are They Really Worth It?
Benzinga via Yahoo Finance· 2 days agoWarren Buffett, the legendary investor and chairman of Berkshire Hathaway, has been a long-standing...
One stock is dragging down the S&P 500's earnings growth
AOL· 3 days agoCompanies in the S&P 500 (^GSPC) have reported what's broadly been considered a solid Q1 earnings season for the index, with one key exception: drugmaker Bristol Myers Squibb (BMY). Last month ...